| Primary |
|
| Drug Ineffective |
50.0% |
| Pulmonary Sarcoidosis |
50.0% |
|
| Secondary |
| Hiv Infection |
67.1% |
| Drug Use For Unknown Indication |
11.0% |
| Antiretroviral Therapy |
6.2% |
| Drug Exposure During Pregnancy |
2.6% |
| Mycobacterium Avium Complex Infection |
2.2% |
| Prophylaxis |
1.3% |
| Pneumocystis Jiroveci Infection |
1.1% |
| Cytomegalovirus Infection |
1.1% |
| Hepatitis C |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.9% |
| Antiviral Prophylaxis |
0.8% |
| Product Used For Unknown Indication |
0.7% |
| Retroviral Infection |
0.7% |
| Factor Viii Deficiency |
0.7% |
| Gastric Ulcer |
0.5% |
| General Symptom |
0.5% |
| Hypersensitivity |
0.5% |
| Cytomegalovirus Chorioretinitis |
0.4% |
| Hiv Test Positive |
0.4% |
| Antifungal Prophylaxis |
0.4% |
|
| Vomiting |
15.6% |
| Progressive External Ophthalmoplegia |
9.9% |
| Portal Hypertension |
9.2% |
| Sepsis |
7.1% |
| Varices Oesophageal |
5.7% |
| Pulmonary Hypertension |
5.0% |
| Nodular Regenerative Hyperplasia |
4.3% |
| Rash |
4.3% |
| Swelling |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Lipodystrophy Acquired |
3.5% |
| Ophthalmoplegia |
3.5% |
| Progressive Multifocal Leukoencephalopathy |
3.5% |
| Neoplasm Malignant |
2.8% |
| Portal Vein Thrombosis |
2.8% |
| Pre-eclampsia |
2.8% |
| Pyrexia |
2.8% |
| Supraventricular Tachycardia |
2.8% |
| Viral Mutation Identified |
2.8% |
| Virologic Failure |
2.8% |
|
| Concomitant |
| Hiv Infection |
58.6% |
| Drug Use For Unknown Indication |
11.4% |
| Acquired Immunodeficiency Syndrome |
5.4% |
| Product Used For Unknown Indication |
5.1% |
| Systemic Antiviral Treatment |
2.9% |
| Antiretroviral Therapy |
2.8% |
| Atypical Mycobacterial Infection |
2.2% |
| Maternal Exposure Timing Unspecified |
1.8% |
| Trigeminal Neuralgia |
1.7% |
| Cd4 Lymphocytes Decreased |
1.4% |
| Diarrhoea Infectious |
1.1% |
| Hepatitis C |
1.1% |
| Tuberculosis |
1.0% |
| Burkitt's Lymphoma |
0.8% |
| Hypercholesterolaemia |
0.6% |
| Pneumonia |
0.6% |
| Prophylaxis |
0.6% |
| Anal Cancer |
0.4% |
| Convulsion |
0.4% |
| Hyperuricaemia |
0.4% |
|
| Vomiting |
16.4% |
| Pseudomembranous Colitis |
9.1% |
| Lipoatrophy |
7.3% |
| Transaminases Increased |
7.3% |
| Renal Failure |
5.5% |
| Urticaria |
5.5% |
| Visual Disturbance |
5.5% |
| Visual Field Defect |
5.5% |
| Abortion Missed |
3.6% |
| Death |
3.6% |
| Liver Function Test Abnormal |
3.6% |
| Rhabdomyolysis |
3.6% |
| Thrombocytopenia |
3.6% |
| Vertigo |
3.6% |
| Viral Load Increased |
3.6% |
| Weight Decreased |
3.6% |
| Weight Increased |
3.6% |
| Blood Triglycerides Increased |
1.8% |
| Cleft Lip |
1.8% |
| Cushing's Syndrome |
1.8% |
|
| Interacting |
| Hiv Infection |
72.7% |
| Suppressed Lactation |
18.2% |
| Major Depression |
9.1% |
|
| Drug Interaction |
33.3% |
| Peripheral Coldness |
33.3% |
| Vomiting |
33.3% |
|
